Trang chủ

Minocycline hydrochloride

Minocycline hydrochloride

Thông số

13614-98-7Số CAS
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochlorideTên IUPAC
C23H28ClN3O7Công thức hóa học
493.9 g/molKhối lượng phân tử
MINOCYCLINE HYDROCHLORIDE; 13614-98-7; Minocycline HCl; Arestin; Minomycin; Minocin; Solodyn; Dynacin; Periocline; Ximino; Vectrin; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride; Minocycline (hydrochloride); Minomax; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride; DTXSID8044545; MFCD00083669; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride; Mynocine hydrochloride; Minocycline (as hydrochloride); NSC 141993; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride; 0020414E5U; Tri-mino; NSC-141993; C23H28ClN3O7; DTXCID6024545; Acnez; Minomycin chloride; (4S-(4alpha,4aalpha,5aalpha,12aalpha))-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride; EINECS 237-099-7; Minocycline hydrochloride (internal use); Lederderm; Mynocine; UNII-0020414E5U; NCGC00096006-01; Prestwick_626; Arestin (TN); Dynacin (TN); Minocin (TN); Solodyn (TN); Minocycline hydrochloride [USP:JAN]; Minocyclinhydrochlorid; AMZEEQ; EMROSI; MINOLIRA; ZILXI; minomycin hydrochloride; SCHEMBL2537; CAS-13614-98-7; Minocycline hydrochloride CRS; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-; MLS002548863; SPECTRUM1500414; FXFM-244; orb1226450; orb1309771; orb3139885; CHEMBL1200881; SCHEMBL27275823; MSK4104; HMS1568P12; Pharmakon1600-01500414; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride;[4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride; Tox21_111250; Tox21_113183; Tox21_301590; CCG-40107; EBC-99036; HB4617; HY-17412R; NSC757120; s4226; MINOCYCLINE HYDROCHLORIDE [MI]; Minocycline hydrochloride, crystalline; AKOS015951312; Minocycline for system suitability CRS; Minocycline hydrochloride (JP18/USP); Tox21_111250_1; AM11587; CS-1256; Minocycline (hydrochloride) (Standard); MINOCYCLINE HYDROCHLORIDE [JAN]; NC00460; NSC-757120; MINOCYCLINE HYDROCHLORIDE [MART.]; MINOCYCLINE HYDROCHLORIDE [VANDF]; NCGC00178854-03; NCGC00255988-01; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride; AC-22362; AK183886; AS-75306; DA-75552; HY-17412; MINOCYCLINE HYDROCHLORIDE [USP-RS]; MINOCYCLINE HYDROCHLORIDE [WHO-DD]; PD003090; SMR001906766; SY007836; M2288; M3353; NS00076430; D00850; MINOCYCLINE HYDROCHLORIDE [ORANGE BOOK]; SBI-0051449.0002; MINOCYCLINE HYDROCHLORIDE [USP MONOGRAPH]; SR-01000075625; SR-01000075625-1; Q27104777; Minocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard; Minocycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Minocycline hydrochloride, United States Pharmacopeia (USP) Reference Standard; (4S,12aS,4aS,5aR)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide Hydrochloride; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide hydrochloride; (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide--hydrogen chloride (1/1); (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamidehydrochloride; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride (1:1), (4S,4aS,5aR,12aS)-; 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, MONOHYDROCHLORIDE, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,12A.ALPHA.))-; Minocycline Hydrochloride HydrateTên gọi khác